Mml Investors Services, LLC Clovis Oncology, Inc. Transaction History

Mml Investors Services, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.7 - $4.76 $194,764 - $343,362	-72,135 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.06 - $5.8 $101 - $145	25 Added 0.03%	72,135 $322,000
Q2 2021 Aug 13, 2021	BUY	$5.02 - $7.05 $27,097 - $38,055	5,398 Added 8.09%	72,110 $418,000
Q1 2021 May 14, 2021	SELL	$4.81 - $10.34 $339,528 - $729,879	-70,588 Reduced 51.41%	66,712 $468,000
Q4 2020 Feb 12, 2021	BUY	$4.13 - $6.41 $240,366 - $373,062	58,200 Added 73.58%	137,300 $659,000
Q3 2020 Nov 13, 2020	BUY	$4.82 - $7.72 $45,308 - $72,568	9,400 Added 13.49%	79,100 $461,000
Q2 2020 Aug 14, 2020	BUY	$5.69 - $9.69 $236,704 - $403,104	41,600 Added 148.04%	69,700 $470,000
Q1 2020 May 14, 2020	BUY	$3.77 - $11.0 $105,937 - $309,100	28,100 New	28,100 $178,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Mml Investors Services, LLC with notifications on news.